During the initial treatment for T-ALL, expressions of CD4, CD8, CD5, CD7, cCD3, and partial TDT were detected, and lack of mature B cells and myeloid antigen hematopoietic precursor cells was observed. This evidence concerns the gene CD8A and acute lymphoblastic leukemia.